MedPath

VitaHealth ESO-Reliv Tablet

Registration Number: MAL16075042NCR

Approved
Approval ID

5a4214aa3f977408

Registration Number

MAL16075042NCR

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types8 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (8)

30tablet TabletsAvailable
Package Size: 30tablet Tablets
Status: NPRA Approved
60tablet TabletsAvailable
Package Size: 60tablet Tablets
Status: NPRA Approved
90tablet TabletsAvailable
Package Size: 90tablet Tablets
Status: NPRA Approved
100tablet TabletsAvailable
Package Size: 100tablet Tablets
Status: NPRA Approved
120tablet TabletsAvailable
Package Size: 120tablet Tablets
Status: NPRA Approved
150tablet TabletsAvailable
Package Size: 150tablet Tablets
Status: NPRA Approved
180tablet TabletsAvailable
Package Size: 180tablet Tablets
Status: NPRA Approved
300tablet TabletsAvailable
Package Size: 300tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (8)

BETAINE HYDROCHLORIDEActive
Monograph: 甜菜碱
DL-METHIONINEActive
Monograph: Racemethionine
WHEY PROTEIN CONCENTRATEActive
Monograph: Whey
D-CALCIUM PANTOTHENATEActive
Monograph: d-calcium pantothenate
PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6
ZINC OXIDEActive
Monograph: 氧化锌
CYANOCOBALAMINActive
Monograph: 维生素B12
FOLIC ACIDActive
Monograph: 叶酸

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VitaHealth ESO-Reliv Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform